1. Optimized Reference Intervals for Plasma Free Metanephrines in Patients With CKD 
Christina Pamporaki, MD, PhD, Aleksander Prejbisz, MD, Robert Małecki, MD, Frank Pistrosch, MD, Mirko Peitzsch, PhD, Steffen Bishoff, MD, Petra Mueller, MD, Iris Meyer, MD, Doreen Reimann, MD, Katarzyna Hanus, MD, Andrzej Januszewicz, MD, PhD, Stefan R. Bornstein, MD, PhD, Simon Parmentier, MD, PhD, Carola Kunath, BD, Jacques W.M. Lenders, MD, PhD, Graeme Eisenhofer, PhD, Jens Passauer, MD, PhD 
American Journal of Kidney Diseases 
Volume 72, Issue 6, Pages (December 2018)
DOI: /j.ajkd
Copyright © Terms and Conditions

2. Figure 1
Plasma concentrations of free normetanephrine (NMN), metanephrine (MN), and 3-methoxytyramine (3-MTY) in patients with CKD stage 3 and CKD stage 4 or on HD compared to the reference group (ref.).
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © Terms and Conditions